UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.391

Sortiert nach

In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application

Journal of chemical information and modeling, 2019-04, Vol.59 (4), p.1634-1644

2019

Volltextzugriff (PDF)

Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New In Silico Methodologies

Journal of chemical information and modeling, 2020-10, Vol.60 (10), p.5234-5254

2020

Volltextzugriff (PDF)

Clinical Guidelines: A NICE Way to Introduce Cost-Effectiveness Considerations?

Value in health, 2016-07, Vol.19 (5), p.525-530

Drummond, Michael, PhD

2016

Volltextzugriff (PDF)

Improving Medical Device Regulation: The United States and Europe in Perspective

The Milbank quarterly, 2014-03, Vol.92 (1), p.114-150

2014

Volltextzugriff (PDF)

Single cell transcriptomics of human epidermis identifies basal stem cell transition states

Nature communications, 2020-08, Vol.11 (1), p.4239-4239, Article 4239

2020

Volltextzugriff (PDF)

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

BMJ (Online), 2022-01, Vol.376, p.e067975

2022

Volltextzugriff (PDF)

Taking Steps Toward Transparency in Real-World Evidence Studies

Value in health, 2020-09, Vol.23 (9), p.1119-1119

Drummond, Michael F.

2020

Volltextzugriff (PDF)

Is rate of return pricing a useful approach when value-based pricing is not appropriate?

The European journal of health economics, 2019-09, Vol.20 (7), p.945-948

2019

Volltextzugriff (PDF)

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

Value in health, 2013-03, Vol.16 (2), p.e1-e5

2013

Volltextzugriff (PDF)

European union regulation of health technology assessment: what is required for it to succeed?

The European journal of health economics, 2022-08, Vol.23 (6), p.913-915

2022

Volltextzugriff (PDF)

The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review

The European journal of health economics, 2023-09, Vol.24 (7), p.1151-1216

2023

Volltextzugriff (PDF)

Colonoscopy vs the Fecal Immunochemical Test: Which is Best?

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.758-771

2024

Volltextzugriff (PDF)

Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches

Orphanet journal of rare diseases, 2020-07, Vol.15 (1), p.1-189, Article 189

2020

Volltextzugriff (PDF)

Establishing a reasonable price for an orphan drug

Cost effectiveness and resource allocation, 2020-09, Vol.18 (1), p.31-31, Article 31

2020

Volltextzugriff (PDF)

Molecular Control of Atypical Protein Kinase C: Tipping the Balance between Self-Renewal and Differentiation

Journal of molecular biology, 2016-04, Vol.428 (7), p.1455-1464

2016

Volltextzugriff (PDF)

Actin polymerization controls cilia-mediated signaling

The Journal of cell biology, 2018-09, Vol.217 (9), p.3255-3266

2018

Volltextzugriff (PDF)

Data Privacy and Health: How Do We Achieve the Right Balance?

Value in health, 2023-09, Vol.26 (9), p.1283-1285

2023

Volltextzugriff (PDF)

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

Value in health, 2013-03, Vol.16 (2), p.231-250

2013

Volltextzugriff (PDF)

Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

International journal of health policy and management, 2020-06, Vol.9 (6), p.260-262

Drummond, Michael F

2020

Volltextzugriff (PDF)

Twenty-Five Years of Health Economics and Outcomes Research: An Exploration of Value in Health

Value in health, 2023-05, Vol.26 (5), p.617-619

2023

Volltextzugriff (PDF)

‘Mapping’ Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases

PharmacoEconomics, 2020-06, Vol.38 (6), p.557-574

2020

Volltextzugriff (PDF)

Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis

Value in health, 2020-01, Vol.23 (1), p.17-24

2020

Volltextzugriff (PDF)

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

BMC medicine, 2022-01, Vol.20 (1), p.23-23, Article 23

2022

Volltextzugriff (PDF)

When do performance-based risk-sharing arrangements make sense?

The European journal of health economics, 2015-07, Vol.16 (6), p.569-571

Drummond, Michael

2015

Volltextzugriff (PDF)

Cooperative regulation of C1-domain membrane recruitment polarizes atypical protein kinase C

The Journal of cell biology, 2023-10, Vol.222 (10), p.1

2023

Volltextzugriff (PDF)

1 – 25 von 1.391

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.270)
Mit Volltextzugriff
(1.226)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Value In Health
(71)
International Journal Of Technology Assessment In Health Care
(51)
Pharmacoeconomics
(45)
The European Journal Of Health Economics
(25)
The Faseb Journal
(20)
Anesthesiology
(19)
Neuro-Oncology
(18)
Blood
(15)
Health Policy
(15)
Plos One
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application

Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New In Silico Methodologies

Clinical Guidelines: A NICE Way to Introduce Cost-Effectiveness Considerations?

Improving Medical Device Regulation: The United States and Europe in Perspective

Single cell transcriptomics of human epidermis identifies basal stem cell transition states

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

Taking Steps Toward Transparency in Real-World Evidence Studies

Is rate of return pricing a useful approach when value-based pricing is not appropriate?

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

European union regulation of health technology assessment: what is required for it to succeed?

The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review

Colonoscopy vs the Fecal Immunochemical Test: Which is Best?

Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches

Establishing a reasonable price for an orphan drug

Molecular Control of Atypical Protein Kinase C: Tipping the Balance between Self-Renewal and Differentiation

Actin polymerization controls cilia-mediated signaling

Data Privacy and Health: How Do We Achieve the Right Balance?

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

Twenty-Five Years of Health Economics and Outcomes Research: An Exploration of Value in Health

‘Mapping’ Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases

Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

When do performance-based risk-sharing arrangements make sense?

Cooperative regulation of C1-domain membrane recruitment polarizes atypical protein kinase C

Suchergebnisse filtern